Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START)

Betriu, Amadeo; Masotti, Mónica; Serra, Antoni; Alonso, Joaquín; Fernández‐Avilés, Francisco; Gimeno, Federico; Colman, Thierry; Zueco, Javier; Delcán, Juan L.; Garcı́a, Eulogio; Calabuig, J

doi:10.1016/s0735-1097(99)00366-6

Cited by 127 publications

(58 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In early studies, warfarin was used as the standard antithrombotic treatment. 38,47,[51][52][53]56,79,80,82 Ticlopidine has been used more commonly in recent years. In some trials, 57,61 the drug regimen for the stent patients was changed from warfarin to ticlopidine owing to the increased risk of bleeding complications.…”

Section: Adjunctive Treatmentmentioning

confidence: 99%

“…However, the comparison of DES and BMS for single-vessel disease does not involve any question of mortality and therefore can easily be represented in a much simpler way. [52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69]70+ CIC In this section we introduce a simplified model for this purpose, which can be presented on a single Excel worksheet and encapsulates virtually all the detail of the original LRIG model for comparison of stents.…”

Section: Economic Modelling: Simplified Model For Non-drug Eluting Vementioning

confidence: 99%

See 1 more Smart Citation

Coronary artery stents: a rapid systematic review and economic evaluation

Hill¹,

Bagust²,

Bakhai³

et al. 2004

Health Technol Assess

144

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public...

show abstract

Section: Adjunctive Treatmentmentioning

confidence: 99%

Section: Economic Modelling: Simplified Model For Non-drug Eluting Vementioning

confidence: 99%

Coronary artery stents: a rapid systematic review and economic evaluation

Hill¹,

Bagust²,

Bakhai³

et al. 2004

Health Technol Assess

144

View full text Add to dashboard Cite

show abstract

“…Coronary arteries larger than 3 mm are considered good candidates for revascularization, and the benefit of coronary stenting has been consistently demonstrated in coronary vessels >3 mm in diameter. [22][23][24] It is well known that restenosis after percutaneous coronary intervention is influenced by vessel diameter and stent occlusion is more frequent in small vessels leading to controversy regarding the utility of stenting in small vessels <3 mm in diameter. 25,26 The issue of small coronary stenting has been addressed in numerous prospective randomized trials of vessels <3 mm in diameter which were analyzed in 2 meta-analyses of the overall results.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic accuracy and discrimination of ischemia by fractional flow reserve CT using a clinical use rule: Results from the Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography study

Thompson

Raju

Blanke

et al. 2015

Journal of Cardiovascular Computed Tomography

View full text Add to dashboard Cite

show abstract

“…[15][16][17][18][19] The need for emergency CABG during the hospitalization was as low as 0.7% in the present study, which might be, at least in part, because of the availability of coronary stents; recent studies have shown the decline of emergency CABG after the introduction of stents and newer adjuvant pharmacological agents. 20 Other factors may also have contributed to this lower rate of emergency CABG in Japan, such as increasing operator volume and hospital experience of PCI.…”

Section: Discussionmentioning

confidence: 99%